SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form POS AM - Post-Effective amendments for registration statement:
SEC Accession No. 0001144204-14-058765
Filing Date
2014-09-30
Accepted
2014-09-30 17:06:16
Documents
9

Document Format Files

Seq Description Document Type Size
1 POS AM v390135_posam.htm POS AM 1324255
2 EXHIBIT 23.1 v390135_ex23-1.htm EX-23.1 2601
3 GRAPHIC tlogo.jpg GRAPHIC 7936
  Complete submission text file 0001144204-14-058765.txt   7022874

Data Files

Seq Description Document Type Size
4 XBRL INSTANCE DOCUMENT antb-20140630.xml EX-101.INS 870445
5 XBRL TAXONOMY EXTENSION SCHEMA antb-20140630.xsd EX-101.SCH 70078
6 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE antb-20140630_cal.xml EX-101.CAL 53558
7 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE antb-20140630_def.xml EX-101.DEF 337391
8 XBRL TAXONOMY EXTENSION LABEL LINKBASE antb-20140630_lab.xml EX-101.LAB 470273
9 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE antb-20140630_pre.xml EX-101.PRE 397104
Mailing Address 1450 INFINITE DRIVE LOUISVILLE CO 80027
Business Address 1450 INFINITE DRIVE LOUISVILLE CO 80027 650-847-1919
AntriaBio, Inc. (Filer) CIK: 0001509261 (see all company filings)

IRS No.: 273440894 | State of Incorp.: DE | Fiscal Year End: 1231
Type: POS AM | Act: 33 | File No.: 333-196093 | Film No.: 141130339
SIC: 2834 Pharmaceutical Preparations